Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\23568600
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Curr+Oncol+Rep
2013 ; 15
(3
): 207-16
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
The role of vascular endothelial growth factor in the pathogenesis, diagnosis and
treatment of malignant pleural effusion
#MMPMID23568600
Bradshaw M
; Mansfield A
; Peikert T
Curr Oncol Rep
2013[Jun]; 15
(3
): 207-16
PMID23568600
show ga
Malignant pleural effusions (MPEs) are a significant source of cancer-related
morbidity. Over 150,000 patients in the United States suffer from breathlessness
and diminished quality of life due to MPE each year. Current management
strategies are of mostly palliative value and focus on symptom control; they do
not address the pathobiology of the effusion, nor do they improve survival.
Further elucidation of the pathophysiological mechanisms, coupled with the
development of novel treatments such as intrapleural chemotherapeutics targeting
this process, has the potential to greatly improve the efficacy of our current
management options. Vascular endothelial growth factor-A (VEGF-A) has been
implicated as a critical cytokine in the formation of malignant pleural
effusions. Elevated levels of VEGF produced by tumor cells, mesothelial cells,
and infiltrating immune cells result in increased vascular permeability, cancer
cell transmigration, and angiogenesis. Therefore antiangiogenic therapies such as
Bevacizumab, a monoclonal antibody targeting VEGF-A, may have a potential role in
the management of malignant pleural effusions. Herein we review the pathogenesis
and potential treatment strategies of malignant pleural effusions, with a focus
on angiogenesis and antiangiogenic therapeutics.
|Angiogenesis Inhibitors/*therapeutic use
[MESH]
|Antibodies, Monoclonal, Humanized/*therapeutic use
[MESH]